Vaccinex, Inc. Derivative Asset
Vaccinex, Inc. (VCNX) had Derivative Asset of $14 as of 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Balance Sheet › Assets
us-gaap:DerivativeAssets · last filed 2024-11-14
- 2024-09-30: Derivative Asset $14.00.
- 2024-06-30: Derivative Asset $14.00.
- 2024-03-31: Derivative Asset $95.00.
| Period end | Derivative Asset |
|---|---|
| 2024-09-30 | $14.00 10-Q · filed 2024-11-14 |
| 2024-06-30 | $14.00 10-Q · filed 2024-08-14 |
| 2024-03-31 | $95.00 10-Q · filed 2024-05-15 |